Bolt Biotherapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2020 | — | — | $11.6M |
| Jun 2020 | — | — | $45.3M |
| Sep 2020 | — | — | $17.8M |
| Dec 2020 | $46.2M | $46.5M | $5.5M |
| Mar 2021 | $21.4M | $324.6M | $95.5M |
| Jun 2021 | $51.2M | $347.1M | $58.3M |
| Sep 2021 | $58.6M | $333.6M | $23.6M |
| Dec 2021 | $57.6M | $307.7M | $27.4M |
| Mar 2022 | $54.4M | $282.8M | $44.0M |
| Jun 2022 | $52.3M | $260.2M | $22.6M |
| Sep 2022 | $57.1M | $245.5M | $10.6M |
| Dec 2022 | $56.3M | $227.8M | $9.2M |
| Mar 2023 | $48.5M | $206.2M | $14.8M |
| Jun 2023 | $48.6M | $190.7M | $13.5M |
| Sep 2023 | $47.1M | $175.4M | $9.2M |
| Dec 2023 | $47.0M | $159.8M | $10.8M |
| Mar 2024 | $38.7M | $142.9M | $4.3M |
| Jun 2024 | $38.3M | $124.2M | $6.2M |
| Sep 2024 | $37.3M | $109.3M | $9.4M |
| Dec 2024 | $42.4M | $99.6M | $7.2M |
| Mar 2025 | $39.1M | $85.9M | $8.4M |
| Jun 2025 | $36.7M | $75.5M | $9.6M |
| Sep 2025 | $33.0M | $65.1M | $17.8M |
| Dec 2025 | $30.2M | $56.7M | $11.7M |
| Mar 2026 | $28.2M | $48.0M | $11.6M |
| Jun 2026 | $27.7M | $40.3M | $12.9M |